Page 32 - Accelerate Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article TUCSON, Ariz., April 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in Tucson, Arizona that will be a hub for the company's supply chain, serving as a final-stage manufacturing and sterilization center.   The new 120,000 square-foot facility will be built on approximately 32 acres at the northeast corner of Valencia and Kolb Road and is planned to be operational in mid-2022.  BD plans to add approxima...

Share this article Share this article TUCSON, Ariz., Feb. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and full year ended December 31, 2020. "We were pleased with the improvement in our go-live execution over the course of 2020, which drove a material increase in our live instruments in the fourth quarter and led to a 63% increase in our revenue-generating installed base during the year," commented Jack Phillips, Chief Executive Officer of Accelerate Diagnostics, Inc. "We also saw modest improvements in the de...

19 The Antimicrobial Susceptibility Testing Market research study considers the present scenario of the market and With major regions, from angles of manufacturers, product types and end industries. It covers a detailed overview of several market growth industry analysis, restraints, and trends. The report covers both the demand and supply aspects of the market. This research report on the Antimicrobial Susceptibility Testing market covers sizing and forecast, market share, industry trends, growth drivers, and vendor analysis. For enhancing readers’ experience, the report starts with a ba...

Share it When Accelerate Diagnostics last week filed a $150 million shelf registration with the Securities and Exchange Commission (SEC) to signal a possible future share offering, it was one of almost 60 companies to do so in just the first month of the year — the highest in a decade.  Should companies continue to make filings at the same rate as in January, this year could turn out to be record-setting for the tactic. The strategy gives companies the flexibility to raise capital quickly through a stock offering, but without the obligation to actually do so, should they decide the market...

Share this article Share this article TUCSON, Ariz., Feb. 1, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 18, 2020, at 4:00 p.m. Eastern Time. A live audiocast of the session will be accessible through the company's investor relations website at  ir.axdx.com. A replay of the audiocast will be available for at least 30 days following the conference. About Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. is...